Media

Beth Calitri

Corporate Communications, Media Relations

978.417.2031

[email protected]

Sort by Year

September 12, 2012

Ironwood Pharmaceuticals to Present at the UBS Global Life Sciences Conference

September 6, 2012

Ironwood Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Conference

August 30, 2012

Ironwood and Forest to Host Conference Call to Discuss FDA Approval of LINZESS™ (Linaclotide) for the Treatment of Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation

August 30, 2012

Ironwood and Forest Announce FDA Approval of LINZESS™ (Linaclotide) for the Treatment of Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation

July 17, 2012

Ironwood Pharmaceuticals Provides Second Quarter 2012 Investor Update

July 10, 2012

Ironwood Pharmaceuticals to Host Second Quarter 2012 Investor Update Call

May 29, 2012

Ironwood Pharmaceuticals to Present at Upcoming Investor Conferences

May 14, 2012

Ironwood and Forest to Present 17 Linaclotide-Related Abstracts at Digestive Disease Week® 2012

May 8, 2012

Ironwood Pharmaceuticals to Present at Bank of America Merrill Lynch 2012 Health Care Conference

May 1, 2012

Ironwood Pharmaceuticals Provides First Quarter 2012 Investor Update

April 24, 2012

Ironwood Pharmaceuticals to Host First Quarter 2012 Investor Update Call

April 23, 2012

Ironwood and Forest Announce FDA Has Extended the Review Period for Linaclotide to September 2012

February 28, 2012

Ironwood Pharmaceuticals Provides Fourth Quarter 2011 Investor Update

February 27, 2012

Ironwood Pharmaceuticals to Present at Cowen and Company Annual Health Care Conference

February 21, 2012

Ironwood Pharmaceuticals to Host Fourth Quarter 2011 Investor Update Call

Copyright © 2021, Ironwood Pharmaceuticals, Inc. All Rights Reserved

LINZESS®, CONSTELLA®, IRONWOOD® and their associated logos are trademarks of Ironwood Pharmaceuticals, Inc. Any other trademarks referred to herein are the property of their respective owners. All rights reserved.